Genedx Holdings [WGS] vs Danaher [DHR] Detailed Stock Comparison
Genedx Holdings
NASDAQ
Loading...
Danaher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Genedx Holdings wins in 3 metrics, Danaher wins in 16 metrics, with 0 ties. Danaher appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Genedx Holdings | Danaher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 1,507.81 | 44.88 | Danaher |
| Price-to-Book Ratio | 12.50 | 2.89 | Danaher |
| Debt-to-Equity Ratio | 41.27 | 35.45 | Danaher |
| PEG Ratio | -11.21 | -1.20 | Genedx Holdings |
| EV/EBITDA | 112.31 | 22.16 | Danaher |
| Profit Margin (TTM) | 0.39% | 14.21% | Danaher |
| Operating Margin (TTM) | 8.73% | 20.12% | Danaher |
| EBITDA Margin (TTM) | 8.73% | 20.12% | Danaher |
| Return on Equity | 0.60% | 6.68% | Danaher |
| Return on Assets (TTM) | 1.05% | 4.01% | Danaher |
| Free Cash Flow (TTM) | $-33.99M | $5.30B | Danaher |
| 1-Year Return | 265.52% | -21.68% | Genedx Holdings |
| Price-to-Sales Ratio (TTM) | 9.56 | 6.29 | Danaher |
| Enterprise Value | $3.32B | $166.64B | Danaher |
| EV/Revenue Ratio | 9.17 | 6.94 | Danaher |
| Gross Profit Margin (TTM) | 69.04% | 59.35% | Genedx Holdings |
| Revenue per Share (TTM) | $13 | $33 | Danaher |
| Earnings per Share (Diluted) | $0.08 | $4.70 | Danaher |
| Beta (Stock Volatility) | 2.08 | 0.76 | Danaher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Genedx Holdings vs Danaher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Genedx Holdings | 2.83% | 20.19% | 54.68% | 98.65% | 12.06% | 58.68% |
| Danaher | 0.34% | 5.17% | 9.37% | 10.46% | 3.13% | -8.22% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Genedx Holdings | 265.52% | 221.77% | 1,189.39% | 1,189.39% | 1,189.39% | 1,189.39% |
| Danaher | -21.68% | -18.64% | 14.50% | 260.93% | 763.76% | 1,053.88% |
Performance & Financial Health Analysis: Genedx Holdings vs Danaher
| Metric | WGS | DHR |
|---|---|---|
| Market Information | ||
| Market Cap | $3.47B | $151.04B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 695,061 | 3,241,650 |
| 90 Day Avg. Volume | 865,664 | 4,189,007 |
| Last Close | $126.36 | $210.93 |
| 52 Week Range | $28.86 - $127.36 | $171.00 - $279.90 |
| % from 52W High | -0.78% | -24.64% |
| All-Time High | $417.42 (Aug 09, 2021) | $296.06 (Sep 06, 2021) |
| % from All-Time High | -69.73% | -28.75% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | 0.03% |
| Quarterly Earnings Growth | 0.46% | -0.39% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.14% |
| Operating Margin (TTM) | 0.09% | 0.20% |
| Return on Equity (TTM) | 0.01% | 0.07% |
| Debt to Equity (MRQ) | 41.27 | 35.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.65 | $73.10 |
| Cash per Share (MRQ) | $4.68 | $4.13 |
| Operating Cash Flow (TTM) | $13.02M | $6.17B |
| Levered Free Cash Flow (TTM) | $20.21M | $3.88B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Genedx Holdings vs Danaher
| Metric | WGS | DHR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 1,507.81 | 44.88 |
| Forward P/E | 246.17 | 25.17 |
| PEG Ratio | -11.21 | -1.20 |
| Price to Sales (TTM) | 9.56 | 6.29 |
| Price to Book (MRQ) | 12.50 | 2.89 |
| Market Capitalization | ||
| Market Capitalization | $3.47B | $151.04B |
| Enterprise Value | $3.32B | $166.64B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.17 | 6.94 |
| Enterprise to EBITDA | 112.31 | 22.16 |
| Risk & Other Metrics | ||
| Beta | 2.08 | 0.76 |
| Book Value per Share (MRQ) | $9.65 | $73.10 |
Financial Statements Comparison: Genedx Holdings vs Danaher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | WGS | DHR |
|---|---|---|
| Revenue/Sales | $102.69M | $5.74B |
| Cost of Goods Sold | $31.79M | $2.23B |
| Gross Profit | $70.90M | $3.51B |
| Research & Development | $14.87M | $379.00M |
| Operating Income (EBIT) | $8.96M | $1.27B |
| EBITDA | $15.39M | $1.87B |
| Pre-Tax Income | $10.56M | $1.13B |
| Income Tax | $-246,000 | $175.00M |
| Net Income (Profit) | $10.81M | $954.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | WGS | DHR |
|---|---|---|
| Cash & Equivalents | $99.70M | $1.99B |
| Total Current Assets | $225.82M | $9.53B |
| Total Current Liabilities | $69.54M | $6.65B |
| Long-Term Debt | $111.71M | $15.98B |
| Total Shareholders Equity | $257.41M | $50.86B |
| Retained Earnings | $-1.36B | $44.91B |
| Property, Plant & Equipment | $51.39M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | WGS | DHR |
|---|---|---|
| Operating Cash Flow | $-1.74M | $1.47B |
| Capital Expenditures | $-6.13M | $-239.00M |
| Free Cash Flow | $4.05M | $1.05B |
| Debt Repayment | $-911,000 | N/A |
| Common Stock Repurchase | N/A | $-1.08B |
Short Interest & Institutional Ownership Analysis
| Metric | WGS | DHR |
|---|---|---|
| Shares Short | 3.64M | 8.45M |
| Short Ratio | 3.87 | 1.93 |
| Short % of Float | 0.25% | 0.01% |
| Average Daily Volume (10 Day) | 695,061 | 3,241,650 |
| Average Daily Volume (90 Day) | 865,664 | 4,189,007 |
| Shares Outstanding | 28.02M | 719.10M |
| Float Shares | 19.64M | 637.22M |
| % Held by Insiders | 0.12% | 0.11% |
| % Held by Institutions | 1.08% | 0.83% |
Dividend Analysis & Yield Comparison: Genedx Holdings vs Danaher
| Metric | WGS | DHR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |